Dr ULVI BAYRAKTUTAN ULVI.BAYRAKTUTAN@NOTTINGHAM.AC.UK
Associate Professor
Prognostic, diagnostic and therapeutic potential of endothelial progenitor cells for patients with ischaemic stroke: Hype or Hope
Bayraktutan, Ulvi
Authors
Abstract
Ischaemic stroke is a debilitating disease with immense personal, societal and economic impact. Thrombolysis with recombinant tissue plasminogen activator remains the only approved pharmacotherapy for this disease. As each year less than 1% of eligible patients receive this therapy worldwide, efficacious new therapeutics are desperately needed. Emerging evidence suggest endothelial progenitor cells (EPCs), capable of repairing damaged vasculature, as one such therapeutics. However, questions regarding their optimal dose, delivery route and in vivo survivability remain largely unanswered. Outgrowth endothelial cells, generated in large numbers by ex vivo expansion of EPCs, enable effective assessment of these issues and may eventually serve as off-the-shelf therapeutics. Correlations between circulating EPC levels and stroke outcome imply that EPCs may also serve as clinical biomarkers for stroke. This viewpoint briefly evaluates the current evidence, pinpoints the gaps in the literature and proposes new directions for research.
Citation
Bayraktutan, U. (2022). Prognostic, diagnostic and therapeutic potential of endothelial progenitor cells for patients with ischaemic stroke: Hype or Hope. Biocell, 46(7), 1593-1598. https://doi.org/10.32604/biocell.2022.018679
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 23, 2021 |
Online Publication Date | Jan 5, 2022 |
Publication Date | Mar 17, 2022 |
Deposit Date | Sep 30, 2021 |
Publicly Available Date | Sep 30, 2021 |
Journal | Biocell |
Print ISSN | 0327-9545 |
Electronic ISSN | 1667-5746 |
Publisher | Computers, Materials and Continua (Tech Science Press) |
Peer Reviewed | Peer Reviewed |
Volume | 46 |
Issue | 7 |
Pages | 1593-1598 |
DOI | https://doi.org/10.32604/biocell.2022.018679 |
Keywords | Ischaemic stroke; Endothelial Progenitor Cells; Stroke therapeutics; Clinical biomarkers; Regenerative medicine |
Public URL | https://nottingham-repository.worktribe.com/output/6347793 |
Publisher URL | https://www.techscience.com/biocell/online/detail/18351 |
Files
BIOCELL 2021
(560 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search